Nyxoah (NYXH) Interest & Investment Income (2021 - 2026)
Nyxoah (NYXH) recorded quarterly Interest & Investment Income of $8174.1 in Q1 2026, down 100.0% quarter-over-quarter from $6.9 billion in Q4 2025, and up 196.38% on a YoY basis from $2758.0 in Q1 2025.
Nyxoah (NYXH) Interest & Investment Income (2021 - 2026) Analysis & Trends
Nyxoah's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $8174.1 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 196.38% year-over-year to $8174.1; the TTM figure through Mar 2026 stood at $8174.1 (up 196.38% YoY), while the FY2025 annual figure was $2.1 million, down 73.17% from the prior year.
- Interest & Investment Income was $8174.1 for Q1 2026 at Nyxoah, down from $6.9 billion in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $8.0 billion in Q4 2024 to a low of -$6.7 million in Q2 2022.
- Historically, Interest & Investment Income has averaged $1.7 billion across 5 years, with a median of $6.2 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income tumbled 12970.54% in 2022, then soared 37826.11% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $6.9 billion in 2022, then slumped by 34.91% to $4.5 billion in 2023, then soared by 77.2% to $8.0 billion in 2024, then dropped by 13.29% to $6.9 billion in 2025, then sank by 100.0% to $8174.1 in 2026.
- The last three Interest & Investment Income figures came in at $8174.1 (Q1 2026), $6.9 billion (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | 8,174.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,174.15 |
| Dec 31, 2025 | 6.90 Bn |
| Sep 30, 2025 | 7.67 Mn |
| Jun 30, 2025 | 6.20 Mn |
| Mar 31, 2025 | 2,758.04 |
| Dec 31, 2024 | 7.96 Bn |
| Sep 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | -3.74 Mn |
| Mar 31, 2024 | 1.53 Bn |
| Dec 31, 2023 | 4.49 Bn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 670.84 Mn |
| Dec 31, 2022 | 6.90 Bn |
| Sep 30, 2022 | 11.47 Mn |
| Jun 30, 2022 | -6.66 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 4.20 Bn |
| Sep 30, 2021 | -84,908.69 |
| Jun 30, 2021 | 51,783.67 |